Skip to main content
Top
Published in:

Open Access 01-12-2024 | Antibiotic | Research

Assessing antimicrobial consumption in public and private sectors within the Costa Rican health system: current status and future directions

Authors: José Pablo Díaz-Madriz, Carolina Rojas-Chinchilla, Esteban Zavaleta-Monestel, Shing Mi Ching-Fung, Hugo Marin-Piva, Gustavo H Marin, Lucia Giangreco

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

Antimicrobial resistance is a significant global health threat. Therefore, robust surveillance systems for antimicrobial consumption (AMC) are essential to develop public health strategies. However, Latin American countries, including Costa Rica, face challenges in regularly reporting AMC data. This study aims to estimate and analyse the overall AMC in Costa Rica for 2019.

Methods

This study is a national-level, retrospective, observational, and descriptive analysis of AMC in Costa Rica from 1 January to 31 December 2019. The study followed the World Health Organization (WHO) guidelines for the Surveillance of National AMC. The Anatomical Therapeutic Chemical (ATC) / Defined Daily Doses (DDD) system was used to analyse types of antimicrobials and DDD per 1000 inhabitants per day (DID). Antimicrobial dispensation data from the Costa Rican Social Security Fund (CCSS) represented the public sector, while the private sector data was sourced from IQVIA. The analysis included data from both inpatient and outpatient sectors.

Results

A total AMC of 14.32 DID, of which 12.75 DID was within the public sector and 4.12 DID was within the private sector. Penicillins had the highest consumption nationally and in the public sector, while macrolides and lincosamides predominate in the private sector. According to the WHO-AWaRe (Access-Watch-Reserve) classification, antibiotics predominantly consumed nationally (74.7%) and in the public (83.0%) sectors are categorized under Access, whereas the private (61.0%) sector predominates the Watch category.

Conclusion

This study illustrates the importance of enhancing AMC surveillance by integrating data from both the public and private sectors. The findings indicate an excessive use of “Watch” antimicrobials in the private sector. To address this issue, all sectors and regulatory authorities must play an active and supportive role, in the development of effective, multisectoral policies. The methodology employed in this study is applicable to other Latin American countries, and therefore should be utilized for future analysis AMC in this region.
Literature
3.
go back to reference Talebi Bezmin Abadi A, Rizvanov AA, Haertlé T, Blatt NL. World Health Organization Report: current Crisis of Antibiotic Resistance. BioNanoScience. 2019;9(4):778–88.CrossRef Talebi Bezmin Abadi A, Rizvanov AA, Haertlé T, Blatt NL. World Health Organization Report: current Crisis of Antibiotic Resistance. BioNanoScience. 2019;9(4):778–88.CrossRef
5.
go back to reference GLASS methodology for surveillance of national antimicrobial consumption. Geneva: World Health Organization; 2020. 68 p. GLASS methodology for surveillance of national antimicrobial consumption. Geneva: World Health Organization; 2020. 68 p.
7.
go back to reference Marin GH, Giangreco L, Dorati C, Mordujovich P, Boni S, Mantilla-Ponte H, Alfonso Arvez MaJ, López Peña M, Aldunate González MaF, Ching Fung SM, Barcelona L, Campaña L, Vaquero Orellana A, Orjuela Rodríguez T, Ginés Cantero L, Villar RA, Sandoval Fuentes N, Melero E, Marin-Piva H, Soler G, Gabriel F, Pineda Velandia L, Ojeda Florentín C, Risso Patron S, Ortiz Rivas M, Mendoza Benítez C, Mellado R, Ivanovska V, Muller A, Rojas R, Castro JL. Antimicrobial Consumption in Latin American Countries: first steps of a long road ahead. J Prim Care Community Health. 2022;13:21501319221082346.CrossRefPubMedPubMedCentral Marin GH, Giangreco L, Dorati C, Mordujovich P, Boni S, Mantilla-Ponte H, Alfonso Arvez MaJ, López Peña M, Aldunate González MaF, Ching Fung SM, Barcelona L, Campaña L, Vaquero Orellana A, Orjuela Rodríguez T, Ginés Cantero L, Villar RA, Sandoval Fuentes N, Melero E, Marin-Piva H, Soler G, Gabriel F, Pineda Velandia L, Ojeda Florentín C, Risso Patron S, Ortiz Rivas M, Mendoza Benítez C, Mellado R, Ivanovska V, Muller A, Rojas R, Castro JL. Antimicrobial Consumption in Latin American Countries: first steps of a long road ahead. J Prim Care Community Health. 2022;13:21501319221082346.CrossRefPubMedPubMedCentral
8.
go back to reference Durán CE, Christiaens T, Acosta Á, Vander Stichele R. Systematic review of cross-national drug utilization studies in Latin America: methods and comparability: cross-national DU studies in Latin America. Pharmacoepidemiol Drug Saf. 2016;25(1):16–25.CrossRefPubMed Durán CE, Christiaens T, Acosta Á, Vander Stichele R. Systematic review of cross-national drug utilization studies in Latin America: methods and comparability: cross-national DU studies in Latin America. Pharmacoepidemiol Drug Saf. 2016;25(1):16–25.CrossRefPubMed
9.
go back to reference Jayatilleke K. Challenges in implementing Surveillance Tools of High-Income Countries (HICs) in low Middle Income Countries (LMICs). Curr Treat Options Infect Dis. 2020;12(3):191–201.CrossRefPubMedPubMedCentral Jayatilleke K. Challenges in implementing Surveillance Tools of High-Income Countries (HICs) in low Middle Income Countries (LMICs). Curr Treat Options Infect Dis. 2020;12(3):191–201.CrossRefPubMedPubMedCentral
16.
go back to reference Jiménez JFP, Alvarado-Prado R. Financiamiento del sistema de salud en Costa Rica: Experiencias y opciones a partir de la evidencia internacional. Friedrich-Ebert-Stiftung (FES). 2022;37. Jiménez JFP, Alvarado-Prado R. Financiamiento del sistema de salud en Costa Rica: Experiencias y opciones a partir de la evidencia internacional. Friedrich-Ebert-Stiftung (FES). 2022;37.
17.
go back to reference Lista Oficial de Medicamentos y Normativa. 2024. Caja Costarricense de Seguro Social Dirección de Farmacoepidemiologia. 2024;(13):439. Lista Oficial de Medicamentos y Normativa. 2024. Caja Costarricense de Seguro Social Dirección de Farmacoepidemiologia. 2024;(13):439.
18.
go back to reference Lista Oficial de Medicamentos y Normativa 2014. Caja Costarricense de Seguro Social Dirección De Farmacoepidemiologia. 2014;321. Lista Oficial de Medicamentos y Normativa 2014. Caja Costarricense de Seguro Social Dirección De Farmacoepidemiologia. 2014;321.
23.
go back to reference WHO AWaRe. (Access, Watch, Reserve) classification of antibiotics for evaluation and monitoring of use, 2023. In: The selection and use of essential medicines 2023: Executive summary of the report of the 24th WHO Expert Committee on the Selection and Use of Essential Medicines, 24–28 April 2023 [Internet]. Geneva: World Health Organization. 2023 [cited 2024 Aug 22]. https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.04. WHO AWaRe. (Access, Watch, Reserve) classification of antibiotics for evaluation and monitoring of use, 2023. In: The selection and use of essential medicines 2023: Executive summary of the report of the 24th WHO Expert Committee on the Selection and Use of Essential Medicines, 24–28 April 2023 [Internet]. Geneva: World Health Organization. 2023 [cited 2024 Aug 22]. https://​www.​who.​int/​publications/​i/​item/​WHO-MHP-HPS-EML-2023.04.
24.
go back to reference International language for drug utilization research. ATC/DDD System [Internet]. 13. WHO Collaborating Center for Drug Statistics Methodology, Norwegian Institute of Public Health. 2023 [cited 2024 Jan 7]. https://www.whocc.no/ International language for drug utilization research. ATC/DDD System [Internet]. 13. WHO Collaborating Center for Drug Statistics Methodology, Norwegian Institute of Public Health. 2023 [cited 2024 Jan 7]. https://​www.​whocc.​no/​
25.
go back to reference Zarb P, Ansari F, Muller A, Vankerckhoven V, Davey G, Goossens P. Drug utilization 75% (DU75%) in 17 European hospitals (2000–2005): results from the ESAC-2 hospital care sub project. Curr Clin Pharmacol. 2011;6(1):62–70.CrossRefPubMed Zarb P, Ansari F, Muller A, Vankerckhoven V, Davey G, Goossens P. Drug utilization 75% (DU75%) in 17 European hospitals (2000–2005): results from the ESAC-2 hospital care sub project. Curr Clin Pharmacol. 2011;6(1):62–70.CrossRefPubMed
30.
go back to reference Seale AC, Gordon NC, Islam J, Peacock SJ, Scott JAG. AMR Surveillance in low and middle-income settings - a roadmap for participation in the global Antimicrobial Surveillance System (GLASS). Wellcome Open Res. 2017;2:92.CrossRefPubMedPubMedCentral Seale AC, Gordon NC, Islam J, Peacock SJ, Scott JAG. AMR Surveillance in low and middle-income settings - a roadmap for participation in the global Antimicrobial Surveillance System (GLASS). Wellcome Open Res. 2017;2:92.CrossRefPubMedPubMedCentral
32.
go back to reference Díaz-Madriz JP, Zavaleta‐Monestel E, Chaverri‐Fernández JM, Arguedas‐Chacón S, Arguedas‐Herrera R, Leiva‐Montero B, Vásquez‐Mendoza AF, Muñoz‐Gutiérrez G. Impact of a pharmacist‐driven antimicrobial stewardship program on the prescription of antibiotics by intensive care physicians in a latin American hospital: a retrospective study. JACCP J Am Coll Clin Pharm. 2022;5(11):1148–55.CrossRef Díaz-Madriz JP, Zavaleta‐Monestel E, Chaverri‐Fernández JM, Arguedas‐Chacón S, Arguedas‐Herrera R, Leiva‐Montero B, Vásquez‐Mendoza AF, Muñoz‐Gutiérrez G. Impact of a pharmacist‐driven antimicrobial stewardship program on the prescription of antibiotics by intensive care physicians in a latin American hospital: a retrospective study. JACCP J Am Coll Clin Pharm. 2022;5(11):1148–55.CrossRef
33.
go back to reference Chaverri-Fernández JM, Cordero-García E, Díaz-Madriz JP, Moya-Blanco M, Vega-Brown Y. Revisión Del uso de antibióticos de amplio espectro en El ambiente hospitalario privado en Costa Rica. Acta Médica Costarric. 2014;56(4):158–62. Chaverri-Fernández JM, Cordero-García E, Díaz-Madriz JP, Moya-Blanco M, Vega-Brown Y. Revisión Del uso de antibióticos de amplio espectro en El ambiente hospitalario privado en Costa Rica. Acta Médica Costarric. 2014;56(4):158–62.
34.
go back to reference Díaz-Madriz JP, Cordero-García E, Chaverri-Fernández JM, Zavaleta-Monestel E, Murillo-Cubero J, Piedra-Navarro H, Hernández-Guillén M, Jiménez-Méndez T. Impact of a pharmacist-driven antimicrobial stewardship program in a private hospital in Costa Rica. Rev Panam Salud Pública. 2020;44:1.CrossRef Díaz-Madriz JP, Cordero-García E, Chaverri-Fernández JM, Zavaleta-Monestel E, Murillo-Cubero J, Piedra-Navarro H, Hernández-Guillén M, Jiménez-Méndez T. Impact of a pharmacist-driven antimicrobial stewardship program in a private hospital in Costa Rica. Rev Panam Salud Pública. 2020;44:1.CrossRef
35.
go back to reference Adebisi YA. Balancing the risks and benefits of antibiotic use in a globalized world: the ethics of antimicrobial resistance. Glob Health. 2023;19:27.CrossRef Adebisi YA. Balancing the risks and benefits of antibiotic use in a globalized world: the ethics of antimicrobial resistance. Glob Health. 2023;19:27.CrossRef
37.
go back to reference Liu E, Linder KE, Kuti JL. Antimicrobial stewardship at transitions of Care to Outpatient settings: Synopsis and Strategies. Antibiotics. 2022;11(8):1027.CrossRefPubMedPubMedCentral Liu E, Linder KE, Kuti JL. Antimicrobial stewardship at transitions of Care to Outpatient settings: Synopsis and Strategies. Antibiotics. 2022;11(8):1027.CrossRefPubMedPubMedCentral
38.
go back to reference Leung AKC, Wong AHC, Hon KL. Community-Acquired Pneumonia in Children. Recent Pat Inflamm Allergy Drug Discov. 2018;12(2):136–44.CrossRefPubMed Leung AKC, Wong AHC, Hon KL. Community-Acquired Pneumonia in Children. Recent Pat Inflamm Allergy Drug Discov. 2018;12(2):136–44.CrossRefPubMed
40.
go back to reference Kuo SC, Shih SM, Lauderdale TLY, Chang IS, Chen YC, Hsiung CA, Chang SC. Policy-driven revolution of prescription record in outpatient use of fluoroquinolones. J Microbiol Immunol Infect. 2020;53(1):133–40.CrossRefPubMed Kuo SC, Shih SM, Lauderdale TLY, Chang IS, Chen YC, Hsiung CA, Chang SC. Policy-driven revolution of prescription record in outpatient use of fluoroquinolones. J Microbiol Immunol Infect. 2020;53(1):133–40.CrossRefPubMed
41.
go back to reference Claeys KC, Hopkins TL, Vega AD, Heil EL. Fluoroquinolone Restriction as an effective antimicrobial stewardship intervention. Curr Infect Dis Rep. 2018;20(5):7.CrossRefPubMed Claeys KC, Hopkins TL, Vega AD, Heil EL. Fluoroquinolone Restriction as an effective antimicrobial stewardship intervention. Curr Infect Dis Rep. 2018;20(5):7.CrossRefPubMed
43.
go back to reference Yaghoubi S, Zekiy AO, Krutova M, Gholami M, Kouhsari E, Sholeh M, Ghafouri Z, Maleki F. Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review. Eur J Clin Microbiol Infect Dis. 2022;41(7):1003–22.CrossRefPubMed Yaghoubi S, Zekiy AO, Krutova M, Gholami M, Kouhsari E, Sholeh M, Ghafouri Z, Maleki F. Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review. Eur J Clin Microbiol Infect Dis. 2022;41(7):1003–22.CrossRefPubMed
45.
go back to reference Fuentes Bolaños CE. Apuntes de la formación de especialidades medicas en la CCSS. Rev Cienc Adm Financ Segur Soc. 2001;9(2):71–6. Fuentes Bolaños CE. Apuntes de la formación de especialidades medicas en la CCSS. Rev Cienc Adm Financ Segur Soc. 2001;9(2):71–6.
48.
go back to reference European Observatory on Health Systems and Policies, editors. Strengthening health system governance: better policies, stronger performance. Maidenhead, Berkshire: Open University; 2016. p. 272. (European observatory on health systems and policies series). European Observatory on Health Systems and Policies, editors. Strengthening health system governance: better policies, stronger performance. Maidenhead, Berkshire: Open University; 2016. p. 272. (European observatory on health systems and policies series).
Metadata
Title
Assessing antimicrobial consumption in public and private sectors within the Costa Rican health system: current status and future directions
Authors
José Pablo Díaz-Madriz
Carolina Rojas-Chinchilla
Esteban Zavaleta-Monestel
Shing Mi Ching-Fung
Hugo Marin-Piva
Gustavo H Marin
Lucia Giangreco
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
Antibiotic
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-20670-y